Abhishek Chatterjee

Barasat Barrackpore Rd
Kolkata, WB 700126, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 112 publications

Preventing Post-induction Hypotension During General Anaesthesia: A Dose-Response Study of Ringer's Lactate Guided by the Inferior Vena Cava Collapsibility Index.

Preventing Post-induction Hypotension During General Anaesthesia: A Dose-Response Study of Ringer's Lactate Guided by the Inferior Vena Cava Collapsibility Index.

Journal: Cureus
Published: June 02, 2026

Comment on: Group 4 Medulloblastomas of Early Childhood Treated With High-Dose Chemotherapy- and Craniospinal Irradiation-Sparing Approach-Finding the Right Balance Between Survival and Survivorship.

Comment on: Group 4 Medulloblastomas of Early Childhood Treated With High-Dose Chemotherapy- and Craniospinal Irradiation-Sparing Approach-Finding the Right Balance Between Survival and Survivorship.

Journal: Pediatric blood & cancer
Published: March 30, 2026

Pharmacological Targeting of Peroxisome 
Proliferator-activated Receptors for Prevention 
of Radiation-induced Cognitive Decline.

Pharmacological Targeting of Peroxisome 
Proliferator-activated Receptors for Prevention 
of Radiation-induced Cognitive Decline.

Journal: Annals of neurosciences
Published: March 06, 2026

Craniospinal irradiation plus tumor-bed boost with standard adjuvant chemotherapy OR high-dose chemotherapy plus autologous stem cell transplant as a radiation-sparing approach in WNT medulloblastoma of early childhood: Fire OR Ice?

Craniospinal irradiation plus tumor-bed boost with standard adjuvant chemotherapy OR high-dose chemotherapy plus autologous stem cell transplant as a radiation-sparing approach in WNT medulloblastoma of early childhood: Fire OR Ice?

Journal: Journal of neuro-oncology
Published: February 18, 2026

Clinical and genetic predictors of temozolomide-induced severe myelotoxicity in adult diffuse glioma: a case-control study.

Clinical and genetic predictors of temozolomide-induced severe myelotoxicity in adult diffuse glioma: a case-control study.

Journal: Journal of neuro-oncology
Published: January 16, 2026

Patterns of radiation-induced subependymal enhancement in patients with high-grade glioma.

Patterns of radiation-induced subependymal enhancement in patients with high-grade glioma.

Journal: The neuroradiology journal
Published: January 06, 2026

H3K27M-altered diffuse midline glioma: Experience and outcomes from a low-middle income country setting in the contemporary era.

H3K27M-altered diffuse midline glioma: Experience and outcomes from a low-middle income country setting in the contemporary era.

Journal: Neuro-oncology advances
Published: December 19, 2025

A Randomized Controlled Trial Comparing Intrathecal 0.5% Hyperbaric Levobupivacaine and 0.75% Hyperbaric Ropivacaine for Elective Caesarean Section.

A Randomized Controlled Trial Comparing Intrathecal 0.5% Hyperbaric Levobupivacaine and 0.75% Hyperbaric Ropivacaine for Elective Caesarean Section.

Journal: Cureus
Published: December 14, 2025

In Regard to Gal et al.

In Regard to Gal et al.

Journal: International journal of radiation oncology, biology, physics
Published: November 01, 2025

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 07, 2025

Proton versus photon radiotherapy in adults with primary brain tumors evaluating functional survival: a phase 3 randomized controlled trial study protocol (PRIDE).

Proton versus photon radiotherapy in adults with primary brain tumors evaluating functional survival: a phase 3 randomized controlled trial study protocol (PRIDE).

Journal: Radiation oncology (London, England)
Published: July 26, 2025

RAGE signaling pathway in glioblastoma and cognitive decline: Insights into inflammatory mechanisms and therapeutic implications.

RAGE signaling pathway in glioblastoma and cognitive decline: Insights into inflammatory mechanisms and therapeutic implications.

Journal: Brain research
Published: May 30, 2025
Showing 1-12 of 112

Last Updated: 09/26/2026